Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2010
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7837997 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/18/2010WO2010131910A2 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same
11/18/2010WO2010131663A1 Oxamide derivative
11/18/2010WO2010117323A8 Isoxazol-3(2h)-one analogs as therapeutic agents
11/18/2010WO2010080623A3 Anti-fxi antibodies and methods of use
11/18/2010US20100292332 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292268 Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use
11/18/2010US20100292230 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
11/18/2010US20100292200 Methods for Modulating Apoptosis in Platelets
11/18/2010US20100292192 Angiotensin ii receptor antagonists
11/18/2010US20100292183 Tetracycline and uses thereof
11/18/2010US20100292150 Treatment of Menorrhagia with Aromatase Inhibitor
11/18/2010US20100292148 Targeted polylysine dendrimer therapeutic agent
11/18/2010US20100291191 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291085 Antibodies to ox-2/cd200 and uses thereof in inhibiting immune responses
11/18/2010US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
11/18/2010US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010US20100290986 Therapeutic use of diaminophenothiazines
11/17/2010EP2249854A1 Improved treatment and prophylaxis
11/17/2010EP2249837A1 Methods of treating thromboembolic disorders
11/17/2010EP2249835A1 Methods using immunomodulatory compounds for modulating level of cd59
11/17/2010EP2249821A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs
11/17/2010EP1499719B1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
11/17/2010CN1986525B 4-methoxy-1,3-phenyl disulfamide derivative and its application
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101888846A Stable bicarbonate ion-containing drug solution
11/17/2010CN101886066A Treatment effect of tissue plasminogen activator kringle-2 on stroke and preparation method for tissue plasminogen activator kringle-2
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101885730A Compound for resisting thrombus
11/17/2010CN101885684A Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/17/2010CN101884778A Preparation for eliminating insufficiency of spleen and edema
11/17/2010CN101884765A Medicament for treating big belly known as beer belly
11/17/2010CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof
11/17/2010CN101884751A Rapid cough pyemia dispelling drug
11/17/2010CN101884730A Chinese medicinal preparation for treating hypoproteinemia caused by liver damage
11/17/2010CN101884697A Blood nourishing wine
11/17/2010CN101884661A Traditional Chinese medical preparation containing leeches and astragalus and used for treating cardiovascular and cerebrovascular diseases
11/17/2010CN101884656A Traditional Chinese medical composition, preparation method thereof and use thereof
11/17/2010CN101884617A Method for preparing proanthocyanidins liposomes
11/17/2010CN101884410A Peanut, lotus root and rib soup
11/17/2010CN101530561B Hemostyptic medicine
11/17/2010CN101411771B Chinese medicine preparation for treating bleeding symptoms and preparation method thereof
11/17/2010CN101391056B Medicine for treating aplastic anemia
11/17/2010CN101307109B Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use
11/17/2010CN101073666B Method for producing kallidin proenzyme raw-material medicine
11/17/2010CN101040883B Andrographis root extraction and its preparing process and application in preparing antithrombotic medicine
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833697 Endothelial stem cells, populations, methods of isolation and use thereof
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/16/2010CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates
11/11/2010WO2010129890A2 Compounds and methods for inhibiting platelet aggregation
11/11/2010WO2010129379A1 Inhibitors of the renal outer medullary potassium channel
11/11/2010WO2010128446A1 Novel acylated 1,6-anhydro decasaccharide and its use as antithrombotic agent
11/11/2010WO2010078469A3 Sand fly salivary proteins as novel factor xa inhibitors and methods of use
11/11/2010US20100286375 Carrier molecules
11/11/2010US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents
11/11/2010US20100286234 Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286087 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/11/2010US20100286085 Novel chondroitin sulfate having decreased molecular weight and use thereof
11/11/2010US20100286074 Pharmaceutical use of ginsenoside or mixture thereof and pharmaceutical composition of ginsenoside and use thereof
11/11/2010US20100286047 Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
11/11/2010US20100286041 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
11/11/2010US20100285126 Pharmaceutical compositions of fenofibrate
11/11/2010US20100285123 Controlled Release Dosage Formulation of Duloxetine
11/11/2010US20100285064 Adjuvant composition for vaccine
11/11/2010US20100285031 Hox Compositions and Methods
11/11/2010US20100285028 Methods of treating coagulopathy
11/11/2010US20100285027 Antibodies specific for human hepcidin
11/11/2010US20100285021 antihemophilic factor monoclonal antibodies comprising an immunoglobulin heavy chain and light chain amino acid sequences, with modified by enzymatic deglycosylation or by site directed mutagenesis, used for treating hemostasis disorders; anticoagulants
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285004 Anti-CD38 human antibodies and uses thereof
11/11/2010US20100284998 Fibrin sealant
11/11/2010US20100284997 Dosing regimen of activated protein c and variants having reduced anticoagulant activity
11/11/2010US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy
11/11/2010CA2759399A1 Inhibitors of the renal outer medullary potassium channel
11/10/2010EP2248887A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application
11/10/2010EP2247618A1 Ferroportin antibodies and methods of use
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP2247303A1 Haemostasis- modulating compositions and uses therefor
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 671